Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▲Date fromSubject
 20.12.2019Berlin-Chemie AG (BCE)34059ZOVUDEX 125 mg (tbl 7x125 mg (blis.PVC/Al))20.12.2019R
 17.1.2020Berlin-Chemie AG (BCE)34059ZOVUDEX 125 mg (tbl 7x125 mg (blis.PVC/Al))17.1.2020O
 9.11.2020Berlin-Chemie AG (BCE)34059ZOVUDEX 125 mg (tbl 7x125 mg (blis.PVC/Al))9.11.2020O
 14.9.2020Berlin-Chemie AG (BCE)34059ZOVUDEX 125 mg (tbl 7x125 mg (blis.PVC/Al))14.9.2020R
 9.5.2019Berlin-Chemie AG (BCE)34059ZOVUDEX 125 mg (tbl 7x125 mg (blis.PVC/Al))15.5.2019O
 6.5.2020Haleon Czech Republic s.r.o. (HLE)5134AZovirax Duo (crm 1x2 g (tuba Al))6.5.2020O
 3.3.2025Haleon Czech Republic s.r.o. (HLE)5134AZovirax Duo (crm 1x2 g (tuba Al))1.4.2025R
 20.3.2020Haleon Czech Republic s.r.o. (HLE)5134AZovirax Duo (crm 1x2 g (tuba Al))20.3.2020R
 5.6.2025Haleon Czech Republic s.r.o. (HLE)5134AZovirax Duo (crm 1x2 g (tuba Al))29.5.2025O
 30.6.2025GlaxoSmithKline Trading Services Limited (GAG-IRL-3)93191Zovirax 200 mg/5 ml (sus por 1x125 ml (fľ.skl.jantár.+detský bezpeč.uzáver))30.6.2025Z
 18.6.2025Haleon Czech Republic s.r.o. (HLE)90019ZOVIRAX (crm 1x2 g (tuba Al))17.6.2025O
 15.4.2025Haleon Czech Republic s.r.o. (HLE)90020ZOVIRAX (crm 10 g 5%)26.3.2025R
 5.6.2019MSD VACCINS (MSD-FR)36410ZOSTAVAX prášok a disperzné prostredie na injekčnú suspenziu v naplnenej injekčnej striekačke (plv iul 1x >19 400 PFU +1x solv. (skl.liek.+napl.skl.striek.s 2 samost.ihlami))15.9.2019Z
 29.4.2025Zentiva a.s. (ZNT-SK-2)28312ZOPICLON 7,5-SL (tbl flm 20x7,5 mg (blis.PVC/Al))29.4.2025R
 29.4.2025Zentiva a.s. (ZNT-SK-2)28311ZOPICLON 7,5-SL (tbl flm 10x7,5 mg (blis.PVC/Al))29.4.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)